- Report
- May 2024
- 134 Pages
Global
From €6456EUR$6,499USD£5,368GBP
- Report
- April 2024
- 137 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- June 2024
- 180 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- April 2024
- 185 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2024
- 196 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 130 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- November 2024
- 180 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Drug Pipelines
- November 2024
- 60 Pages
Global
From €1490EUR$1,500USD£1,239GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Drug Pipelines
- July 2024
- 180 Pages
Global
From €1739EUR$1,750USD£1,446GBP
€2484EUR$2,500USD£2,065GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more